New Modeling Data Show the Cologuard® Test Has Detected More Than 623,000 Cancers and Precancers Over Past Decade, Saving U.S. Health Care System $22 BillionBusiness Wire • 08/15/24
Wall Street Analysts Predict a 45.04% Upside in Exact Sciences (EXAS): Here's What You Should KnowZacks Investment Research • 08/06/24
Why Exact Sciences, Up 20%, Is 'Coiled To Snap Back' After Quarterly BeatInvestors Business Daily • 08/01/24
U.S. Patent Trial and Appeal Board Institutes Inter Partes Review Based on Geneoscopy's Petition Challenging Validity of ‘781 Patent Owned by Exact SciencesBusiness Wire • 07/29/24
Exact Sciences (EXAS) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseZacks Investment Research • 07/24/24
Exact Sciences Awards Grants to 28 Organizations Focused on Increasing Colorectal Cancer ScreeningBusiness Wire • 07/17/24
Why Is Exact Sciences (EXAS) Down 17.5% Since Last Earnings Report?Zacks Investment Research • 06/07/24
Top 4 Health Care Stocks That Are Preparing To Pump This Month - Inhibrx Biosciences (NASDAQ:INBX)Benzinga • 06/05/24